You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Litigation Details for Cubist Pharmaceuticals LLC v. Sagent Pharmaceuticals, Inc. (D. Del. 2015)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Cubist Pharmaceuticals LLC v. Sagent Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Sign Up .

Details for Cubist Pharmaceuticals LLC v. Sagent Pharmaceuticals, Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2015-12-16 1 FDA. 10. United States Patent No. 6,468,967 (“the ’967 patent”), entitled “Methods for Administration…CUBICIN® prior to the expiration of U.S. Patent Nos. 6,468,967; 6,852,689; 8,058,238; and 8,129,342. … Infringement of U.S. Patent No. 6,468,967 23. Plaintiff incorporates … 1. This is an action for patent infringement under the patent laws of the United States, Title…2019. 11. United States Patent No. 6,852,689 (“the ’689 patent”), entitled “Methods for Administration External link to document
2015-12-16 3 /9/15. Date of Expiration of Patent: The 6,468,967 and 6,852,689 patents expire on September 24, 2019.… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2019. The 8,058,238 and 8,129,342 patents expire on November 18, 2020..Thirty Month Stay Deadline: 5/9/2018…2015 2 March 2016 1:15-cv-01164 830 Patent None District Court, D. Delaware External link to document
2015-12-16 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,468,967 B1; 6,852,689 B2; 8,058,238…2015 2 March 2016 1:15-cv-01164 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.